Quality Initiative in Clinical Practice: A Single-Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Bischin, Alina M; Vishnu, Prakash; Chen, Ruqin; Knopf, Kevin B; Aboulafia, David M

Bischin, Alina M; Vishnu, Prakash; Chen, Ruqin; Knopf, Kevin B; Aboulafia, David M.

Afiliación

Bischin AM; School of Medicine, University of Washington, Seattle.
Vishnu P; Division of Hematology, Mayo Clinic, Jacksonville, FL.
Chen R; Division of Hematology, Mayo Clinic, Jacksonville, FL.
Knopf KB; Department of Hematology/Oncology, Highland Hospital, Oakland, CA.
Aboulafia DM; Division of Hematology, University of Washington, Seattle.

Mayo Clin Proc Innov Qual Outcomes ; 3(4): 485-494, 2019 Dec.

Article en En | MEDLINE | ID: mdl-31993568

Palabras clave

ASH-PIM, American Society of Hematology Practice Improvement Module; BMB, bone marrow biopsy; CT, computed tomography; DLBCL, diffuse large B-cell lymphoma; EMR, electronic medical record; G-CSF, granulocyte colony-stimulating factor; HAART, highly active antiretroviral therapy; HBV, hepatitis B virus; HCV, hepatitis C virus; NHL, non-Hodgkin lymphoma; PET, positron emission tomography; QII, quality improvement initiative; R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; VMMC, Virginia Mason Medical Center

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Revista: Mayo Clin Proc Innov Qual Outcomes Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google